Biotech Collaborations, Other Actions in Agriculture and Animals: Jan. 1 - Nov. 23, 2004 Nov. 29, 2004
Tysabri's Physician Uptake Remains Question Mark Nov. 29, 2004 By Randy Osborne Earlier this month when Biogen Idec Inc. at last unveiled one-year data from its Phase III trial known as AFFIRM, hopes of investors - not to mention multiple sclerosis patients - ran high for the would-be blockbuster Antegren (natalizumab).Read More
Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Sept. 17 - Nov. 17, 2004 Nov. 22, 2004
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Sept. 17 - Nov. 17, 2004 Nov. 22, 2004
Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Sept. 17 - Nov. 17, 2004 Nov. 22, 2004
Biotech-Biotech Collaborations: Modified And Terminated Agreements, Sept. 17 - Nov. 17, 2004 Nov. 22, 2004
RSS